Get the app!
Back to Companies

Tempest Therapeutics, Inc.

TPSTNasdaqCIK: 0001544227

Tempest Therapeutics, Inc. (TPST) shows 12 recent insider filings from 6 insiders, with all of them on the buy side. With $1.0M in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $1.0M). Angel Matthew is the most active by dollar volume, and the single largest transaction was $1.5M by Angel Matthew. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$2.7M
Purchases
$1.0M
Sales
$0
Unique Insiders
6

Recent Insider Trades

12 loaded
Nov 3TPST
Tempest Therapeutics, Inc.
Horn-Warnock StephanieCFO, Treasurer, & Corp Sec.Other$0
Nov 2TPST
Tempest Therapeutics, Inc.
Frederick John W.DirectorOther$0
Nov 2TPST
Tempest Therapeutics, Inc.
Frederick John W.DirectorAward$18.5K
Oct 2TPST
Tempest Therapeutics, Inc.
Smith Nancy FredaDirectorOther$0
Oct 2TPST
Tempest Therapeutics, Inc.
Smith Nancy FredaDirectorAward$25.0K
Jun 8TPST
Tempest Therapeutics, Inc.
Richey William DrakeInsiderAward$31.8K
Jun 8TPST
Tempest Therapeutics, Inc.
Richey William DrakeInsiderOther$0
Jun 17TPST
Tempest Therapeutics, Inc.
Yee John D.InsiderAward$31.8K
Jun 17TPST
Tempest Therapeutics, Inc.
Yee John D.InsiderOther$0
Jun 23TPST
Tempest Therapeutics, Inc.
Angel MatthewInsiderBuy$500.0K
Mar 25TPST
Tempest Therapeutics, Inc.
Angel MatthewInsiderBuy$500.0K
Feb 6TPST
Tempest Therapeutics, Inc.
Angel MatthewInsiderAward$641.7K

12 filings